Accession Number: | 0001328143-21-000059 |
Date: | 2021-06-02 |
Issuer: | ADAMAS PHARMACEUTICALS INC (ADMS) |
Original Submission Date: |
MAHONEY DAVID L
C/O ADAMAS PHARMACEUTICALS, INC.
1900 POWELL ST., SUITE 1000
EMERYVILLE, CA 94608
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-06-02 | A | 5,000 | a | $0.00 | 115,153 | direct | ||
COMMON STOCK | 2021-06-02 | 0 | $0.00 | 2,628 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 5.21 | 2021-06-02 | deemed execution date | A | 10,000 (a) | 2022-06-02 | 2031-06-01 | common stock 10,000 | $5.21 | 10,000 | direct |
ID | footnote |
---|---|
f1 | the shares of common stock are to be acquired upon the vesting of certain restricted stock units granted to the reporting person. the restricted stock units shall vest on the one year anniversary of the grant date, subject to reporting person's continuous service (as defined in the issuer's 2014 equity incentive plan) as of such date. |
f2 | the option shares vest in full on the one year anniversary of the grant date, subject to reporting person's continuous service (as defined in the issuer's 2014 equity incentive plan) as of such date. |